Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Diabetes

  • 1
    News

    SGLT-2 inhibitors promising for heart failure prevention, not treatment

    January 12, 2019

    LOS ANGELES – The combination of heart failure and diabetes is particularly lethal.

  • 1
    News

    New diabetes drugs solidify their cardiovascular and renal benefits

    January 7, 2019

    CHICAGO – Empagliflozin’s heart failure and renal benefits surprised when reported in 2015. The evidence has grown stronger and broader since.

  • 1
    News

    Nasal glucagon ‘viable alternative’ to intramuscular administration

    November 20, 2018

    BERLIN – Severe hypoglycemia was reversed successfully in all patients with type 1 diabetes mellitus given nasal glucagon.

  • 1
    Opinion

    Transforming glycemic control at Norwalk Hospital

    November 20, 2018

    Norwalk Hospital created a Glycemic Care Team to focus on improving the quality of care for inpatients with diabetes.

  • 1
    News

    Lower glucose targets show improved mortality in cardiac patients

    November 9, 2018

    Lower blood glucose targets in critically ill cardiac patients are associated with lower 30-day mortality, compared with higher targets.

  • 1
    News

    Perioperative diabetes and HbA1c in mortality

    October 4, 2018

    Do preoperative hemoglobin A1c (HbA1c) and perioperative glucose predict outcomes in patients undergoing noncardiac and cardiac surgeries?

  • 1
    News

    Review protocols, follow reprocessing guidelines to cut device-related HAIs

    September 11, 2018

    Environmental pathogens associated with medical devices or device reprocessing are often the cause of HAI-related investigations.

  • 1
    News

    Plan now for outpatient diabetes tech in the hospital

    September 4, 2018

    ORLANDO – Getting ahead of the diabetes tech curve.

  • 1
    News

    Hospitalists target inpatient glycemic control

    August 13, 2018

    Hyperglycemia in hospitalized patients is an extraordinarily common and growing problem.

  • 1
    News

    Intranasal naloxone promising for type 1 hypoglycemia

    July 17, 2018

    ORLANDO – This development could help prevent autonomic failure in T1DM patients.

Previous1 … 10 11 12 13 14Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences